Disease managementBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7234.588/a (Published 26 February 2000) Cite this as: BMJ 2000;320:588
- Douglas Carnall (email@example.com)
Those of us who look on in bewilderment at the US ability to commercialise anything will find such brash commercial solutions for human suffering as disease management distasteful. This week's BMJ carries a critique of the US “health” marketplace, in which “disease management” is the next big thing.
In any such development there will be good and bad, and …